Tian DY, Yang DF, Xia NS, Zhang ZG, Lei HB, Huang YC. Serological prevalence and risk factor analysis of hepatitis G virus infection in Hubei Province of China. World J Gastroenterol 2000; 6(4): 585-587 [PMID: 11819653 DOI: 10.3748/wjg.v6.i4.585]
Corresponding Author of This Article
De-Ying Tian, Department of Infectious Diseases, Tongji Hospital, Tongji Medical University, Wuhan, 430030, Hubei Province, China. tianyawu@sina.com
Article-Type of This Article
Brief Reports
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Aug 15, 2000; 6(4): 585-587 Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.585
Table 1 Positive rates of anti-HGV and HGV RNA in drug users and prostitutes
n
Anti-HGV
HGV RNA
Drug users*
po
211
6.63 (14)
27.96 (49)
iv
164
12.20 (20)
32.92 (54)
Prostitutes
Non-addict
22
9.09 (2)
13.36 (3)
Addict
76
14.43 (36)
22.36 (17)
Healthy group
55
1.82 (1)
0 (0)
Table 2 Risk factors of HGV infections in drug users
Sex
Addiction duration
HBV infection
Male
Female
< 2 years
≥ 2 years
HBsAg (+)
HBsAg (-)
Anti-HGV
8.65
9.23
6.48
12.58
13.33
9.37
HGV RNA
3.46
32.84
9.72
52.56
16.67
22.78
Table 3 HGV infections in the cases of PHC, hemodialysis, liver or kidney tran splantation
n
Anti-HGV
HGV RNA in anti-HGV (+) cases
Hemodialysis
61
13.11 (8/61)
37.50 (3/8)
PHC
41
4.80 (2/41)
100.00 (2/2)
Liver transplantation
3
33.30 (1/3)
100.00 (1/1)
Kidney transplantation
53
1.82 (1/53)
0
Total
158
7.5 (12/158)
50.00 (6/12)
Table 4 Positive rates of anti-HGV and HGV RNA in patients with viral hepatitis
n
Anti-HGV
HGV RNA in anti-HGV (+) cases
Hepatitis A
35
14.29 (5/35)
20.00 (1/5)
Hepatitis B
214
17.29 (37/214)
35.14 (13/37)
Hepatitis C
62
14.52 (9/62)
55.56 (5/9)
Hepatitis E
25
4.00 (1/25)
0
Hepatitis NA-E
15
26.67 (4/15)
50.00 (2/4)
Total
351
15.05 (56/351)
37.50 (21/56)
Citation: Tian DY, Yang DF, Xia NS, Zhang ZG, Lei HB, Huang YC. Serological prevalence and risk factor analysis of hepatitis G virus infection in Hubei Province of China. World J Gastroenterol 2000; 6(4): 585-587